Batm Advanced Communicat... Share Discussion Threads

[paulisi] 13/2/2015 22:08

When are the results out? Last year they came out on 25/02.

[spekky] 13/2/2015 20:01

"As a reference, Optidet® has the potential to save a mid-size hospital in the U.S. approximately $22 million a year, next to generating much less waste (saving on waste disposal costs). In addition, patients benefit from better care with quicker results."

If this claim is even half true..........we are in for a nice ride on the medical side......fingers crossed.

[fse] 12/2/2015 22:36

Interesting and yes you are correct about this spekky ....
link to "optidet"

[spekky] 11/2/2015 20:43

Just putting this here for future ref.I think Adaltis will be producing the final version of the Optidet and I think it will have a big impact in 2016.

@paulisi........I think they might give notice of results but not actual results........imho.

[paulisi] 11/2/2015 20:09

The EGM is tomorrow. Are results out at the same time?

[rob1ng] 11/2/2015 09:56

So is Bvc harnessing the power of Labradors nose sense to build digital cancer analysers from humans breath ,looks like this technology is becoming viable ,good for the medical division and us

[fse] 02/2/2015 22:12

A link for the header if possible

BATM wholly owned subsidiary in Rome

Edit added
Link to Adaltis tests

[fse] 02/2/2015 16:32

Good news to offset the apparent Israeli infrastructure Telco fiasco.
Medical arm set to become the dominant business for BATM.
I can't help but think that once they get to the point that they are making decent money from reagent re supply then we will be looking at a very different picture.
It will be most interesting to see what % reagent re supply occupies in the company's revenue model. Its essentially gravy ......

[james dean] 02/2/2015 07:39

TIDMBVC

RNS Number : 6967D

BATM Advanced Communications Ld

02 February 2015

2 February 2015

BATM Advanced Communications Limited

("BATM" or "the Group")

Diagnostic Kit for Antibody to Hepatitis C Virus (ELISA) Granted Licence for Sale in China

Sales and marketing authorisation opens up opportunity to target huge market with millions of people suffering from the deadly hepatitis C virus

BATM Advanced Communications Limited (LSE: BVC; TASE: BATM), a leading provider of real-time technologies for the networked telecoms and medical laboratory equipment markets, is pleased to announce that the Group's diagnostics business has been granted a licence by the China Food and Drug Administration of People's Republic of China for the importation, marketing and sale in China of its diagnostic kit for hepatitis C, which it identifies by detecting antibodies to the virus using an ELISA screen.

Initially, the Group will commence targeting hospitals in the Shanghai province and shipments of the first units are expected to commence in H2 2015. Following this, the Group plans to roll out the sales and marketing efforts to other provinces in China.

Hepatitis C is a liver disease caused by the hepatitis C virus. It is a blood-borne virus and the most common modes of infection are through unsafe injection practices; inadequate sterilization of medical equipment in some healthcare settings; and unscreened blood and blood products. According to the World Health Organisation (WHO), in 2014, 130-150 million people globally had chronic hepatitis C infection, with the most affected regions being Central and East Asia and North Africa.

BATM's diagnostics business is focused on developing compact, high accuracy, cost effective products for small to mid-size laboratories, including advanced genomic solutions that are being introduced to the market. In particular, the Group is targeting markets where many laboratories are mid-sized and dispersed in different localities - and hence require the solutions provided by the Group's diagnostics business.

Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are delighted to have been granted this licence - our most significant in China to date. China is the world's largest market for hepatitis C diagnostics and we believe that this approval will pave the way for the granting of licences for several more reagents that we have submitted for approval. Hepatitis C disease currently has no vaccine and it is estimated to kill approximately 350,000 to 500,000 every year - a number far greater than the recent tragedy spread by the Ebola virus. Antiviral medicine can cure the infection, but access to diagnosis and treatment is low because the symptoms are not obvious. Our ambition is to ensure that the diagnosis of this killer virus, in China and elsewhere, becomes a standard and its prevalence is reduced through proper care and treatment."

Enquiries

BATM Advanced Communications
---------------------------------------------------
Dr Zvi Marom, Chief Executive
Officer [phone]
-------------------------------- -----------------
Moti Nagar, Chief Financial
Officer
-------------------------------- -----------------

finnCap
---------------------------------------------------
Stuart Andrews [phone]
-------------------------------- -----------------

Shore Capital
---------------------------------------------------
Pascal Keane [phone]
-------------------------------- -----------------

Luther Pendragon
---------------------------------------------------
Harry Chathli, Claire Norbury,
Amelia Bullock-Muir [phone]
-------------------------------- -----------------


This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCDBGDDLBGBGUB

[fse] 30/1/2015 15:50

Its true this once vaunted ultra modern fiber op roll out for all of Israel has certainly NOT burst into life as expected.
Not good news as it would underpin Telco systems finances going forwards.
Once again politics ruins what ought to have been in everybody's best interests.

[james dean] 30/1/2015 09:53

Hi reeltime -

Thanks very much - interesting.

Regards.

DYOR

[reeltime] 29/1/2015 23:14

The Israeli partners in the fiber-optics venture oppose the replacement of Ze'ev Goldberg with Doron Cohen.

A split is emerging in the board of Israeli fiber-optics venture Israel Broadband Company (IBC) between the Israeli partners on the one hand and Israel Electric Corporation (IEC) and Swedish investor Jonas Birgersson on the other, in the wake of Birgersson and IEC's decision to appoint Doron Cohen, formerly director-general of the Ministry of Finance, as chairman of the venture in place of Ze'ev Goldberg. The Israeli partners, headed by Zvi Marom, controlling shareholder of BATM Advanced Communications Ltd. (LSE: BVC) and a shareholder in the venture, have announced that they will forcefully oppose the move imposed on them and carried out without consultation with them.

Last week, the Israeli partners received notice that it had been decided to oust Goldberg and replace him with Cohen. Goldberg was the investment banker for ViaEuropa in the deal whereby the latter became the controlling shareholder in the venture. After the deal was completed, Goldberg was asked to become chairman. He agreed, and even moved to Israel for the purpose.

It is not clear why Birgersson decided to replace Goldberg with Cohen, but it is clear that the main mover behind the decision was IEC and its chairman Yiftah Ron-Tal. Birgersson's agreement to the appointment of Doron Cohen is an indicator of the balance of forces in the venture and of the fact that it is really run by IEC and not by the shareholders.

IEC holds 40% of the venture, and is the main contractor, and ViaEuropa and the Israeli investors 60%.

In recent months, "Globes" has several times exposed tensions between the Israeli partners and ViaEuropa, chiefly over Birgersson's role and the venture's slow progress. The venture is failing to meet the expectations of those involved, including the state, which expected to see IEC take the fiber-optic market by storm and present a genuine alternative to Bezeq Israeli Telecommunication Co. Ltd. (TASE: BEZQ). In fact, what is happening is that IEC is doing what it wants with the venture, and it is proceeding very slowly.

Zvi Marom says that the Israeli shareholders are demanding that the choice of chairman should be coordinated with them and should be made in a fair and transparent manner for the benefit of the venture. Marom says he will oppose the appointment and will not allow a culture of political appointments to infiltrate the fiber-optics venture, which is supposed to turn Israel digital by connecting all homes to a fiber-optic infrastructure.

Published by Globes [online], Israel business news - www.globes-online.com - on January 25, 2015

[reeltime] 29/1/2015 22:17

Telco Systems Wins Backhaul Distinction Award for High Capacity, Breakthrough 4G Demarcation Device

Company recognized for meeting the challenges of mobile operators, backhaul wholesalers and service providers to cost-effectively connect base stations and controller sites running LTE and LTE Advanced
January 29, 2015 03:18 AM Eastern Standard Time

MANSFIELD, Mass.--(BUSINESS WIRE)--Telco Systems, the leading provider of innovative SDN & NFV and multi-service Carrier Ethernet 2.0 and MPLS edge solutions, today announced that it has won the Sixth Annual Mobility Tech Zone Wireless Backhaul Distinction Award that honors companies who are devoted to innovation as the industry evolves to wireless technologies and infrastructure.

The object of the award, Telco Systems’ T-Marc 3348S, is especially cost-effective as mobile network operators and service providers migrate their networks to 4G. Specifically, T-Marc 3348S is a leap forward in 10GE Carrier Ethernet and MPLS service delivery. With 4x 10GE/1GE SFP+ ports, 4x 10/100/1000Mbps copper ports and 8 dual-speed (100Mbps/1GE) fiber ports, it constitutes one of the densest capacity demarcation devices in the industry and supports redundant power supplies, including a wide range of DC power supplies, making it optimal for cell-site deployment. With a comprehensive set of OAM and SLA monitoring and testing tools in its hardware, the T-Marc 3348S provides accurate, real-time network measurement and service turn-up testing and verification, reducing truck rolls and shortening time for activation and management. It is a true game changer.

“Telco Systems continues to attract recognition for our industry-leading innovations,” declared Ariel Efrati, company CEO. “This latest award is especially gratifying as it acknowledges an inspired product that, at once, boosts backhaul capacity and flexibility, reduces management complexity, and brings cost-of-operation to a new minimum. We are proud to be the recipients of this award as we endeavor to provide the advancements that help network operators and service providers deliver the backhaul networks of the future today.”

The award is presented by Mobility Tech Zone, an online resource for the mobile broadband industry and is sponsored by TMC, a global, integrated media company helping client to build communities in person, in print and online, and Crossfire Media, an integrated marketing company with a core focus on future trends in technology

[spekky] 23/1/2015 20:06

Well now,it appears THERE ARE a few optimists out there besides myself.The dotcom/tech boom has been a rollercoaster (which thankfully I never bought into) BUT, if it's not too stupid an idea,I would suggest that the survivors of the bubble could be entering a "golden age"......my best analogy would be the days when we all boasted of having the smallest one.......(mobile that is).....then it became obvious no-one would want to consume video on a tiny display screen.....so we rewind technology to a more reasonable point.If/when SDN becomes a mature/secure way of operating systems then I would suggest that all things internet have "come of age".......when things cannot be done discernably faster or more securely the cost/benefit analysis of pursuing miniscule improvements do not stack up.......one day soon someone will suggest the Pony Express is the best way to transfer information. :-)

[gclark] 23/1/2015 15:05

So what have we got: a large director share purchase and the main guy wanting to work through another company maybe in expectation of an upsurge in business and/or for it to be available as a buy-out company. I sense confidence in the future - and I share that. Maybe a threat to us is one part of the company being sold off to this other company before the revenues and profits show through.
The medical side was always going to take time to build up - all businesses take time and you have to be patient. I think the returns are coming.
The Telco side offers stuff I find hard to understand technically, but does stuff that operators will want, it is thought. It's doing OK but could take off.
It is easy to complain and moan at 'management', but I have been in BATM since the 1999 era. Clearly it hasn't generated much so far (!) but it has survived which is a lot better than many of my other investments! So I would say pretty sound management in that respect.
They have invested for the future, have two different channels of potential success and growth, financially sound with good cash, I am buying. I think operating in two good markets.
Let's hope ...

[fse] 23/1/2015 15:03

Thats far more the way to look at it. Its far more relevant to look at the current position rather than the past
I never remain invested unless i like the current picture

The company has reinvented itself. The medical side is growing and the prospects are solid. SDN is here and being rapidly adopted reeltime,JD and myself have posted numerous updates on this
Whilst I do once again have a large position here it was not always thus as I was waiting for the dust to settle a bit. I also am invested for the scenario that the Telco division will either gather traction or get shipped out either way this ought to boost the SP

[spekky] 22/1/2015 19:25

I have mostly tried to ignore the frustrations of those true longs because I was more interested (recently) in the medical side,partly due to an interest in reagents and antibody substitutes and the ISS which I believe has a big future.
BUT I find myself thinking that SDN/NFV May yet be the saviour of this company because I believe it is a truly disruptive technology.
My thinking is that in a relatively short time all our medical histories will be cloud based and personalised........porn is dead,medical will get more hits,I only hope batty is onto it.

[fse] 22/1/2015 15:10

I agree its been a torrid period to be invested but this is all coming to a head and they are at least broadly back in profit
For me an share price over 28p would put me seriously into profit and hopefully we will see that sooner than later.
If the company is split then that would achieve that
Still I do agree its been frustrating

[rob1ng] 22/1/2015 14:06

But you have to consider some of us might be dead by the time the share moves up .i was attracted to these when the shares were multi baggers maybe 15 years ago .i have bought these shares at many different levels and probably selling at a loss today .i still own far too many anything above 25p would be good

[fse] 22/1/2015 13:42

Sorry solar are you well seasoned to 40% proof LOL
The weak performance of the company and the tech markets in general over the past 10 yrs is well documented
The positives here are a growing medical division
A struggling telco division which has gambled heavily on emmerging SDN portfolio of equiment. The israeli infrastructure win
The company is well funded owns its own real estate
An experienced investor looks at these factors whilst a well seasoned investor needs to sleep it off.

[fse] 22/1/2015 13:24

Solar. How in the world would you know what I am doing as a total picture
There is a facility called trading!
I actually make use of that
At the present I have been buying back increasing my position
One has to look at the current story not just what happened in the past
There is a real possibility that the company will be split releasing shareholder equity
Maybe you should engage brain before spouting off about other peoples investment
This a thread about BATM not my or anyone elses personal holdings

[solar_br] 22/1/2015 11:17

For anyone who has been invested here for the past few years this has been dead money.

In fact a huge compromise on their cash.


The worst of it is that this has been a dorment investment when the rest of the market has been hitting record highs.


Actually, the fact that Zvi Marom is now seeking to divert his persoal income through another avenue, using the vehicle of a Limited company, speaks volumes - it makes the very distinct and rather elaborate statement of saying nothing is epected to change with regards to the actual business of the company or it's future revenues/structure.


That simply implies continuation of a dormant investment.

[solar_br] 22/1/2015 11:04

FSE,

Surely this company has been pulling the wool over your eyes for the best part of a decade or so ?

I remember when you were a poster on the other thread with MasterRSI many years ago.

MRSI was wise enough to sell out of this several years ago never to look back as he realise the company's chief Dr Z Marom was trying to twist figures and hide the truth which would not have been immediately apparent to the layman investor but which was very clear to the seasoned investor.


The share price of the company is less than half what it was then and it has pretty much stagnated for years.



Whilst you on the other hand stayed invested here with the unfortunate, yet deluded perception of jam tomorrow.


Forget jam tomorrow - it's marmite today and always will be with this company.


Zvi Marom has not changed - he will continue to try and deceive.


The RNS states that the proposals have to go through a vote in accordance with Israeli corporate law .. so it wasn't a case of whether they could pull the wool over your eyes in this instance, though they would have if they could.